project id: TCGA-SKCM; case submitter id: TCGA-DA-A3F2; source center: 23; state: released; a260 a280 ratio: 1.73; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.8; age at index: 55; days to birth: -20365; days to death: 1032; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1955; age at diagnosis: 20365; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1025.0; icd 10 code: C49.6; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of trunk, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 534; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-DA-A3F2-06A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;